Origin of human bone marrow fibroblasts

British Journal of Haematology
D W GoldeR P Gale

Abstract

We investigated the origin of bone marrow fibroblasts in three bone marrow transplant recipients with aplastic anaemia and leukaemia who received grafts from HLA-identical siblings of opposite sex. The patients were conditioned for transplantation with high doses of cytotoxic drugs and 300--1000 rads total body irradiation. After transplantation, bone marrow cells were cultured in T flasks for 3 weeks and the adherent cells were then trypsinized and passaged weekly. After several passages the cells had the typical morphology and growth pattern of fibroblasts. Metaphases from these cells were all of recipient sex type. In contrast, haematopoietic cells and lymphocytes obtained at the same time were of donor sex type. Our findings indicate that the human bone marrow fibroblast is not derived from a precursor common to haemotopoietic cells or lymphocytes. The bone marrow fibroblast appears to be a mesenchymal cell, unrelated to haematopoietic stem cells, which is capable of in vitro proliferation after as much as 1000 rads of total body irradiation.

Citations

Jan 1, 1992·International Journal of Legal Medicine·P BetzW Eisenmenger
Dec 1, 1981·Cancer Genetics and Cytogenetics·R S Sparkes
Oct 1, 1995·Critical Reviews in Oncology/hematology·N Fukushima, H Ohkawa
Nov 13, 1982·Lancet·J F LoutitJ M Vaughan
Mar 2, 1985·Lancet
Dec 12, 2001·British Journal of Haematology·J ScopesF M Gibson
Mar 29, 2002·Kidney International·Esther A GonzálezKeith A Hruska
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P AnklesariaJ S Greenberger
Feb 17, 1999·The Journal of Experimental Medicine·S K NilssonP J Quesenberry
Mar 18, 2003·Transplantation·Gordon D WuDonald V Cramer
Jun 24, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L W PoulsenK Bendix
Mar 1, 1982·Journal of Clinical Pathology·R BurkhardtR Bartl
Dec 1, 1996·Environmental Health Perspectives·D T JonesJ S Hasan
Jan 1, 1991·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·A OhsakaT Yokoyama
Feb 21, 2002·Cancer Investigation·Vincent F La RussaRoy Weiner
Sep 1, 1993·Cell Adhesion and Communication·C O ChichesterJ J Minguell
Nov 1, 1989·Mayo Clinic Proceedings·A M Gewirtz
Jan 1, 1987·Leukemia Research·L DouayN C Gorin
Jan 1, 1985·Leukemia Research·A Islam
Jan 1, 1990·Critical Reviews in Oncology/hematology·R E SmithE J Szabo
Sep 1, 1992·Bone and Mineral·A J FriedensteinI L Moskvina
Oct 1, 1981·British Journal of Haematology·A J Barrett, J Adams
Nov 1, 1984·International Journal of Cell Cloning·P E HollingsM E Beard
Jun 1, 1983·British Journal of Haematology·A H PiersmaK G Brockbank
Mar 1, 1983·British Journal of Haematology·M Y Gordon, E C Gordon-Smith
Aug 7, 2012·Cell Adhesion & Migration·Benjamin G Cuiffo, Antoine E Karnoub
Jan 11, 2003·Biotechnology & Genetic Engineering Reviews·Hervé Petite, Didier Hannouche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.